732 related articles for article (PubMed ID: 9783491)
1. Isolated systolic hypertension: pathophysiology, consequences and therapeutic benefits.
Kocemba J; Kawecka-Jaszcz K; Gryglewska B; Grodzicki T
J Hum Hypertens; 1998 Sep; 12(9):621-6. PubMed ID: 9783491
[TBL] [Abstract][Full Text] [Related]
2. Risk reduction associated with lowering systolic blood pressure: review of clinical trial data.
Hall WD
Am Heart J; 1999 Sep; 138(3 Pt 2):225-30. PubMed ID: 10467217
[TBL] [Abstract][Full Text] [Related]
3. Management of isolated systolic hypertension.
Tonkin A; Wing L
Drugs; 1996 May; 51(5):738-49. PubMed ID: 8861544
[TBL] [Abstract][Full Text] [Related]
4. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.
Staessen JA; Fagard R; Thijs L; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene MR; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A
Arch Intern Med; 1998 Aug 10-24; 158(15):1681-91. PubMed ID: 9701103
[TBL] [Abstract][Full Text] [Related]
5. Treating isolated systolic hypertension in the elderly.
Howard PA
Ann Pharmacother; 1994 Mar; 28(3):367-73. PubMed ID: 8193428
[TBL] [Abstract][Full Text] [Related]
6. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
[TBL] [Abstract][Full Text] [Related]
7. Hypertension in elderly--an overview.
Bhattacharyya A; Das P
J Indian Med Assoc; 1999 Mar; 97(3):96-101. PubMed ID: 10652909
[TBL] [Abstract][Full Text] [Related]
8. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and implications of uncontrolled systolic hypertension.
Kannel WB
Drugs Aging; 2003; 20(4):277-86. PubMed ID: 12641483
[TBL] [Abstract][Full Text] [Related]
10. Isolated systolic hypertension in the elderly: lessons from clinical trials and future directions.
Black HR
J Hypertens Suppl; 1999 Dec; 17(5):S49-54. PubMed ID: 10706327
[TBL] [Abstract][Full Text] [Related]
11. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study.
Psaty BM; Furberg CD; Kuller LH; Borhani NO; Rautaharju PM; O'Leary DH; Bild DE; Robbins J; Fried LP; Reid C
JAMA; 1992 Sep; 268(10):1287-91. PubMed ID: 1387172
[TBL] [Abstract][Full Text] [Related]
12. Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial.
Staessen JA; Thijs L; Gasowski J; Cells H; Fagard RH
Am J Cardiol; 1998 Nov; 82(9B):20R-22R. PubMed ID: 9822139
[TBL] [Abstract][Full Text] [Related]
13. Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators.
Gasowski J; Staessen JA; Celis H; Fagard RH; Thijs L; Birkenhäger WH; Bulpitt CJ; Fletcher AE; Arabidze GG; de Leeuw P; Dollery CT; Duggan J; Kawecka-Jaszcz K; Leonetti G; Nachev C; Safar M; Rodico JL; Rosenfeld J; Seux ML; Tuomilehto J; Webster J; Yodfat Y
J Hum Hypertens; 1999 Feb; 13(2):135-45. PubMed ID: 10100063
[TBL] [Abstract][Full Text] [Related]
14. Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension.
Esposito R; Izzo R; Galderisi M; De Marco M; Stabile E; Esposito G; Trimarco V; Rozza F; De Luca N; de Simone G
J Hum Hypertens; 2016 Jun; 30(6):392-6. PubMed ID: 26355832
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular remodeling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study.
Pini R; Cavallini MC; Bencini F; Silvestrini G; Tonon E; De Alfieri W; Marchionni N; Di Bari M; Devereux RB; Masotti G; Roman MJ
J Am Coll Cardiol; 2002 Oct; 40(7):1283-9. PubMed ID: 12383576
[TBL] [Abstract][Full Text] [Related]
16. Isolated systolic hypertension in the elderly: implications of Systolic Hypertension in the Elderly Program (SHEP) for clinical practice and for the ongoing trials.
Staessen J; Fagard R; Amery A
J Hum Hypertens; 1991 Dec; 5(6):469-74. PubMed ID: 1791605
[TBL] [Abstract][Full Text] [Related]
17. Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach.
Jackson R
J Hum Hypertens; 1998 Sep; 12(9):607-13. PubMed ID: 9783489
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the potential interaction between NaCl and prostaglandin inhibition in elderly individuals with isolated systolic hypertension.
Alam S; Purdie DM; Johnson AG
J Hypertens; 1999 Aug; 17(8):1195-202. PubMed ID: 10466476
[TBL] [Abstract][Full Text] [Related]
19. Isolated systolic hypertension: a new challenge in medicine.
Sulbarán TA; Silva ER; Maestre G
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S44-7. PubMed ID: 11986893
[TBL] [Abstract][Full Text] [Related]
20. Isolated systolic hypertension in the elderly: new insights.
Palatini P; Graniero GR
Clin Exp Hypertens; 1993; 15 Suppl 1():103-16. PubMed ID: 8513303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
